Must-Have Features in a Convenient, Portable Design
The Nellcor™ portable SpO2 patient monitoring system, PM10N, is a convenient, handheld monitor that is ideal for spot-checks or continuous monitoring in various healthcare and home use settings. Its ergonomic shape and simple design make it intuitive to use and simple to operate. Wherever you need accurate, reliable SpO2 measurements, count on the Nellcor™ portable SpO2 pulse oximeter to meet the challenge.
The monitoring system includes a vivid 3-inch color LCD screen, and connectivity to analytic tools and patient management systems. It is compatible with the entire line of Nellcor™ sensors with OxiMax™ technology and offers a robust monitoring feature set including SpO2, pulse rate, SatSeconds alarm management, pleth waveform, blip bar and tabular trend information.
The monitor incorporates Nellcor™ digital signal processing technology to deliver accurate, reliable SpO2 and pulse rate values even during low perfusion and signal interference, including patient motion.
Nellcor™ Portable SpO2 Patient Monitoring System Highlights
Tour the Key Features and Functions of the Monitor
In addition to taking the full length tour, you can quickly review key topic sections of the tutorial video by watching one of the five topic modules.
Tour by Topic:
Nellcor™ Portable SpO2 Patient Monitoring System, PM10N Features
- Small, lightweight, ergonomic handheld monitor for continuous and spot-check pulse oximetry monitoring
- Supports a robust data set, including real-time SpO2 and PR values, SatSeconds alarm management, pleth waveform, blip bar and tabular trend data
- Supports standard and home-care modes for use in hospital, hospital-type facilities, transport, mobile environments and home-care environments
- Supports Sleep Study Mode, which enables the clinician to dim the LCD display and silence alarms to prevent disruption of patients’ sleep
- Nellcor™ advanced signal processing technology delivers reliable operation even in difficult monitoring conditions
- LoSat expanded accuracy range (60% to 100% SpO2) when used with Nellcor™ adhesive sensors with OxiMax™ technology
- Compatible with the complete line of Nellcor™ single-patient-use, reusable and specialty sensors with OxiMax™ technology
- 80 hours of data storage capability
- Supports data export to an external personal computer for data analysis and printing functions
|Weight||274 g (0.604 lbs), including four batteries|
|Dimensions||70 mm W x 156 mm H x 32 mm D|
|(2.76 in W x 6.14 in H x 1.26 in D)|
|Screen size||88.9 mm (3.5 in), measured diagonally|
|Screen type||TFT LCD, white LED backlight, viewing cone of 60º and optimal viewing distance of 1 meter|
|Resolution||320 x 480 pixels|
|Categories||Patient status and system status|
|Priorities||Low, medium and high|
|Notification||Audible and visual|
|Setting||Default, institutional and last setting|
|Alarm volume level||49 to 89 dB|
|Alarm system delay||<10s|
Range and Accuracy
|Range Type||Range Values|
|SpO2 saturation range||1% to 100%|
|Pulse rate range||20 to 250 beats per minute (bpm)|
|Perfusion range||0.03% to 20%|
|Display sweep speed||6.25 mm/sec|
|Adult||70% to 100% ±2 digits|
|Adult and neonate low sat||60 to 80% ±3 digits|
|Neonate||70 to 100% ±2 digits|
|Low perfusion||70 to 100% ±2 digits|
|Adult and neonate with motion||70 to 100% ±3 digits|
|Adult and neonate||20 to 250 bpm ±3 digits|
|Low perfusion||20 to 250 bpm ±3 digits|
|Adult and neonate with motion||20 to 250 bpm ±5 digits|
|Battery||Four new lithium batteries with 3,000 mAh will typically provide 20 hours of monitoring with no external communication, no audible alarm sound and at an ambient temperature of 25° C.|
|Voltage||1.5V x 4|
|Transport and Storage||Operating Conditions|
|Temperature||-20 ºC to 70 ºC,||5 ºC to 40 ºC|
|(-4 ºF to 158 ºF)||(41 ºF to 104 ºF)|
|Altitude||-390 to 5,574 m,||-390 to 5,574 m|
|(-1,280 to 18,288 ft.)||(-1,280 to 18,288 ft.)|
|Relative humidity||15% to 95% non-condensing|
|Memory||Saves total 80 hours data events. Saves date and time, alarm conditions, pulse rate and SpO2 measurements|
|Tabular format||One table for all parameters|
|IEC 60601-1:2005+A1:2012, EN 60601-1:2006/AC:2010|
|IEC 60601-1:1998 + A1:1991 +A2:1995, EN 60601-1:1990 +A11:1993 +A12:1993 +A13:1996|
|IEC 60601-1-2:2007, EN60601-1-2:2007|
|IEC 60601-1-6:2010, EN 60601-1-6:2010 +A1:2013|
|IEC 60601-1-8:2006, EN 60601-1-8:2006 +A1:2012|
|IEC 60601-1-11:2010, EN 60601-1-11:2010|
|ISO 9919:2005, EN ISO 9919:2009|
|ISO 80601-2-61:2011, EN ISO 80601-2-61:2011|
|CAN/CSA C22.2 No. 601.1 M90|
|UL 60601-1: 1st edition|
|802.11 B/G/N WLAN connectivity|
|Type of protection against electric shock||Class I (internally powered)|
|Degree of protection against electric shock||Type BF - applied part|
|Mode of operation||Continuous|
|Electromagnetic compatibility||IEC 60601-1-2:2007|
|Ingress protection||IP22: Protected against foreign objects and moisture|
|Degree of safety||Not suitable for use in the presence of flammable anesthetics|
Providing accurate, reliable SpO2 and pulse rate readings, this portable, easy-to-use device is an ideal solution for these critical screenings:
Critical Congenital Heart Disease Screening
In the United States, about 4,800 (or 11.6 per 10,000) babies are born every year with CCHD. These babies are at significant risk if this condition goes undiagnosed.1 Since 1993, Nellcor™ pulse oximetry technology has been utilized on more than 33,000 newborns spanning five separate clinical studies evaluating the use of pulse oximetry for critical congenital heart disease screening.2-6
Using Nellcor™ pulse oximetry screening has been shown to be a simple and economical tool to aid healthcare providers in CCHD screening.6 The convenient Nellcor™ portable SpO2 patient monitoring system, PM10N, delivers accurate, reliable SpO2 and pulse rate values even during patient motion, and can communicate this information in trend report for data analysis. The ability to accurately measure O2 saturation and heart rate through motion is necessary for an effective CCHD screening. The portability of the system, allows for easy access to the monitor by clinicians and the opportunity for tandem screenings. This enhanced functionality provides information and accuracy clinicians can rely on for this important screening.
Car Seat Challenge Test
For their safety, all new babies are required to leave the hospital in a car seat if they are traveling by car. However, for premature babies improper positioning in child safety restraint systems can possibly lead to respiratory compromise. According to the American Academy of Pediatrics guidelines, as part of the discharge process, each preterm infant born less than 37 weeks gestational age should have a period of observation in a car safety seat before hospital discharge to monitor for possible apnea, bradycardia or oxygen desaturation. Therefore, the American Academy of Pediatrics recommends a Car Seat Challenge Test prior to discharge for infants born less than 37 weeks' gestation.7
The convenient Nellcor™ portable SpO2 patient monitoring system, PM10N, delivers accurate, reliable SpO2 and pulse rate values even during patient motion, and can communicate this information in trend report for data analysis. The ability to accurately measure O2 saturation and heart rate through motion is necessary for an effective Car Seat Challenge Test. The portability of the system, allows for easy access to the monitor by clinicians. Clinicians can feel confident using the portable, reliable Nellcor™ portable SpO2 patient monitoring system for this life-saving patient assessment.
- Centers for Disease Control and Prevention. Pulse Oximetry Screening for Critical Congenital Heart Defects. Available at: http://www.cdc.gov/ncbddd/heartdefects/screening.html.
- Hoke, T.R., et al., Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatr Cardiol, 2002 Jul-Aug. 23(4): p. 403-9.
- Reich, J.D., et al., The use of pulse oximetry to detect congenital heart disease. J Pediatr, 2003 Mar. 142(3): p. 268-72.
- Arlettaz, R., et al., The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr, 2006 Feb. 165(2): p. 94-8.
- Sendelbach, D.M., et al., Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects. Pediatrics, 2008 Oct. 122(4): p. e815-20.
- Walsh, W., Evaluation of pulse oximetry screening in Middle Tennessee: cases for consideration before universal screening. J Perinatol, 2011 Feb. 31(2): p. 125-9.
Nellcor™ Portable SpO2 Patient Monitoring System (PM10N) Information Sheet
Explore detailed product specifications.
View Info Sheet
Nellcor™ Portable SpO2 Patient Monitoring System (PM10N) In-Service Presentation
Learn about key product features and functionality.
Nellcor™ Portable SpO2 Monitor Tutorial Video
Take a virtual tour of the new Nellcor™ portable SpO2 monitor.
Nellcor™ Portable SpO2 Patient Monitoring System for CCHD Screenings
Learn how this portable device can be used as a tool for CCHD screenings.
Nellcor™ Portable SpO2 Patient Monitoring System for the Car Seat Challenge
Learn how this portable device can be used during the Car Seat Challenge.